Document Detail

Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes.
MedLine Citation:
PMID:  22017284     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND PURPOSE: Oxalobacter formigenes (OF) may play a protective role in preventing calcium oxalate stones. This is the first prospective study to evaluate the effect of antibiotics on OF colonization. Intestinal colonization by OF is associated with reduced urinary oxalate excretion. Exposure to antibiotics may be an important factor determining rates of colonization.
MATERIALS AND METHODS: The effect of antibiotics on OF colonization was compared in two groups: A group receiving antibiotics for gastric infection with Helicobacter pylori (HP) and a group without HP whose members were not receiving antibiotics. OF colonization in stool was detected by oxalate degradation at baseline and after 1 and 6 months.
RESULTS: The prevalence at baseline of intestinal colonization with OF was 43.1% among all patients screened. Among the 12 patients who were positive for OF who did not receive antibiotics, 11 (92%) had OF on stool tests at 1 month and 6 months. Of the 19 participants who were positive for OF and who received antibiotics for HP, only 7 (36.8%) continued to be colonized by OF on follow-up stool testing at 1 and 6 months (P=0.003 by Fisher exact test). Amoxicillin and clarithromycin caused 62.5% of subjects to become negative for OF at 1 month; 56.2% remained negative for OF at 6 months.
CONCLUSIONS: Antibiotics for HP infection effectively reduced colonization with OF, an effect present at 1 and 6 months after treatment. The lasting elimination of OF could be associated with hyperoxaluria and be a factor in recurrent kidney stone disease.
Viktoria Kharlamb; Jennifer Schelker; Fritz Francois; Juquan Jiang; Ross P Holmes; David S Goldfarb
Related Documents :
17009134 - Treatment of small congenital nevocellular naevi using a combination of ultrapulse carb...
10727314 - Pendulaser carbon dioxide resurfacing laser versus electrodesiccation with curettage in...
19470864 - Endovenous laser procedure in a clinic room: feasibility and side effects study of 1,70...
21292734 - 28-joint count disease activity score at 3 months after diagnosis of early rheumatoid a...
22184784 - Restoration of active palmar abduction of the thumb in tetraplegia by tendon transfer o...
20347544 - Prospective randomized trial of routine versus selective shunting in carotid endarterec...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-10-21
Journal Detail:
Title:  Journal of endourology / Endourological Society     Volume:  25     ISSN:  1557-900X     ISO Abbreviation:  J. Endourol.     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-09     Completed Date:  2012-02-29     Revised Date:  2013-06-27    
Medline Journal Info:
Nlm Unique ID:  8807503     Medline TA:  J Endourol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1781-5     Citation Subset:  IM    
Pharmacy Benefits Management, Veterans Integrated Service Network 3, New York Harbor Veterans Affairs Medical Center, New York, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Anti-Bacterial Agents / administration & dosage*,  pharmacology*
Colony Count, Microbial
Feces / microbiology
Follow-Up Studies
Helicobacter pylori / drug effects*,  growth & development*
Intestines / drug effects,  microbiology*
Oxalobacter formigenes / drug effects*,  growth & development*
Grant Support
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Evaluation of Laparoscopic Curricula in American Urology Residency Training.
Next Document:  Successful stabilization of graphene oxide in electrolyte solutions: enhancement of biofunctionaliza...